{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T17:44:49Z","timestamp":1760204689518,"version":"3.40.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2014,4,22]],"date-time":"2014-04-22T00:00:00Z","timestamp":1398124800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurotox Res"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1007\/s12640-014-9469-9","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T15:06:57Z","timestamp":1398092817000},"page":"363-381","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Improvement of Mitochondrial Function by Paliperidone Attenuates Quinolinic Acid-Induced Behavioural and Neurochemical Alterations in Rats: Implications in Huntington\u2019s Disease"],"prefix":"10.1007","volume":"26","author":[{"given":"Jitendriya","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,22]]},"reference":[{"issue":"12","key":"9469_CR1","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1139\/cjpp-2013-0185","volume":"91","author":"S Aboul-Fotouh","year":"2013","unstructured":"Aboul-Fotouh S, Elgayar N (2013) Atypical antipsychotics such as risperidone, but not paliperidone, worsen vascular endothelial function via upregulation of adhesion molecules VCAM-1, ICAM-1, and E-selectin in diabetic rats. Can J Physiol Pharmacol 91(12):1119\u20131126","journal-title":"Can J Physiol Pharmacol"},{"key":"9469_CR2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4172\/2161-1459.1000117","volume":"3","author":"C \u00c1lamo","year":"2013","unstructured":"\u00c1lamo C, L\u00f3pez-Mu\u00f1oz F (2013) The pharmacological role and clinical applications of antipsychotics\u2019 active metabolites: paliperidone versus risperidone. Clin Exp Pharmacol 3:117","journal-title":"Clin Exp Pharmacol"},{"issue":"1","key":"9469_CR3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0006-8993(85)91472-6","volume":"341","author":"C Aldinio","year":"1985","unstructured":"Aldinio C, Mazzari S, Toffano G, K\u00f6hler C, Schwarcz R (1985) Effects of intracerebral injections of quinolinic acid on serotonergic neurons in the rat brain. Brain Res 341(1):57\u201365","journal-title":"Brain Res"},{"issue":"8\u20139","key":"9469_CR4","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1139\/y04-061","volume":"82","author":"JW Aldridge","year":"2004","unstructured":"Aldridge JW, Berridge KC, Rosen AR (2004) Basal ganglia neural mechanisms of natural movement sequences. Can J Physiol Pharmacol 82(8\u20139):732\u2013739","journal-title":"Can J Physiol Pharmacol"},{"issue":"1","key":"9469_CR5","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.neuroscience.2008.11.055","volume":"159","author":"L Amori","year":"2009","unstructured":"Amori L, Wu HQ, Marinozzi M, Pellicciari R, Guidetti P, Schwarcz R (2009) Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum. Neuroscience 159(1):196\u2013203","journal-title":"Neuroscience"},{"issue":"4","key":"9469_CR6","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/0896-6273(95)90186-8","volume":"15","author":"M Ankarcrona","year":"1995","unstructured":"Ankarcrona M, Dypbukt JM, Bonfoco E, Zhivotovsky B, Orrenius S, Lipton SA, Nicotera P (1995) Glutamate-induced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 15(4):961\u2013973","journal-title":"Neuron"},{"issue":"2","key":"9469_CR7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1006\/exnr.2000.7514","volume":"166","author":"DM Araujo","year":"2000","unstructured":"Araujo DM, Cherry SR, Tatsukawa KJ, Toyokuni T, Kornblum HI (2000) Deficits in striatal dopamine D2 receptors and energy metabolism detected by in vivo MicroPET imaging in a rat model of Huntington\u2019s disease. Exp Neurol 166(2):287\u2013297","journal-title":"Exp Neurol"},{"issue":"4","key":"9469_CR8","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s002130050726","volume":"139","author":"M Aravagiri","year":"1998","unstructured":"Aravagiri M, Yuwiler A, Marder SR (1998) Distribution after repeated oral administration of different dose levels of risperidone and 9-hydroxy-risperidone in the brain and other tissues of rat. Psychopharmacology 139(4):356\u2013363","journal-title":"Psychopharmacology"},{"key":"9469_CR9","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1038\/cddis.2011.112","volume":"2","author":"D Bano","year":"2011","unstructured":"Bano D, Zanetti F, Mende Y, Nicotera P (2011) Neurodegenerative processes in Huntington\u2019s disease. Cell Death Dis 2:e228","journal-title":"Cell Death Dis"},{"issue":"3","key":"9469_CR10","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1046\/j.1471-4159.1999.0731127.x","volume":"73","author":"SB Berman","year":"1999","unstructured":"Berman SB, Hastings TG (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson\u2019s disease. J Neurochem 73(3):1127\u20131137","journal-title":"J Neurochem"},{"issue":"1","key":"9469_CR11","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12640-009-9051-z","volume":"16","author":"N Braidy","year":"2009","unstructured":"Braidy N, Grant R, Adams S, Brew BJ, Guillemin GJ (2009) Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox Res 16(1):77\u201386","journal-title":"Neurotox Res"},{"issue":"2","key":"9469_CR12","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1745-7254.2005.00525.x","volume":"26","author":"Y Cao","year":"2005","unstructured":"Cao Y, Gu ZL, Lin F, Han R, Qin ZH (2005) Caspase-1 inhibitor Ac-YVAD-CHO attenuates quinolinic acid-induced increases in p53 and apoptosis in rat striatum. Acta Pharmacol Sin 26(2):150\u2013154","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"9469_CR13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0022-3565(24)36396-7","volume":"280","author":"WA Cass","year":"1997","unstructured":"Cass WA (1997) Decreases in evoked overflow of dopamine in rat striatum after neurotoxic doses of methamphetamine. J Pharmacol Exp Ther 280(1):105\u2013113","journal-title":"J Pharmacol Exp Ther"},{"issue":"34","key":"9469_CR14","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1073\/pnas.0502698102","volume":"102","author":"D Charvin","year":"2005","unstructured":"Charvin D, Vanhoutte P, Pages C, Borrelli E, Caboche J (2005) Unraveling a role for dopamine in Huntington\u2019s disease: the dual role of reactive oxygen species and D2 receptor stimulation. Proc Natl Acad Sci U S A 102(34):12218\u201312223","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"18","key":"9469_CR15","doi-asserted-by":"crossref","first-page":"4724","DOI":"10.1016\/S0021-9258(18)62854-6","volume":"245","author":"JB Clark","year":"1970","unstructured":"Clark JB, Nicklas WJ (1970) The metabolism of rat brain mitochondria: preparation and characterization. J Biol Chem 245(18):4724\u20134731","journal-title":"J Biol Chem"},{"key":"9469_CR16","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.brainres.2008.07.021","volume":"1233","author":"P Corena-McLeod Mdel","year":"2008","unstructured":"Corena-McLeod Mdel P, Oliveros A, Charlesworth C, Madden B, Liang YQ, Boules M, Shaw A, Williams K, Richelson E (2008) Paliperidone as a mood stabilizer: a pre-frontal cortex synaptoneurosomal proteomics comparison with lithium and valproic acid after chronic treatment reveals similarities in protein expression. Brain Res 1233:8\u201319","journal-title":"Brain Res"},{"issue":"5","key":"9469_CR17","doi-asserted-by":"crossref","first-page":"e52147","DOI":"10.1371\/journal.pone.0052147","volume":"8","author":"M Corena-McLeod","year":"2013","unstructured":"Corena-McLeod M, Walss-Bass C, Oliveros A, Gordillo Villegas A, Ceballos C, Charlesworth CM, Madden B, Linser PJ, Van Ekeris L, Smith K, Richelson E (2013) New model of action for mood stabilizers: phosphoproteome from rat pre-frontal cortex synaptoneurosomal preparations. PLoS One 8(5):e52147","journal-title":"PLoS One"},{"issue":"1","key":"9469_CR18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/0003-9861(59)90090-6","volume":"82","author":"GL Ellman","year":"1959","unstructured":"Ellman GL (1959) Tissue sulfhydryl groups. Arch Biochem Biophys 82(1):70\u201377","journal-title":"Arch Biochem Biophys"},{"key":"9469_CR19","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/0006-2952(61)90145-9","volume":"7","author":"GL Ellman","year":"1961","unstructured":"Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7:88\u201395","journal-title":"Biochem Pharmacol"},{"key":"9469_CR20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0076-6879(67)10010-4","volume":"10","author":"RW Estabrook","year":"1967","unstructured":"Estabrook RW (1967) Mitochondrial respiratory control and the polarographic measurement of ADP: O ratios. Methods Enzymol 10:41\u201347","journal-title":"Methods Enzymol"},{"issue":"1\u20132","key":"9469_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(00)02237-X","volume":"866","author":"I Ferrer","year":"2000","unstructured":"Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T (2000) Brain-derived neurotrophic factor in Huntington disease. Brain Res 866(1\u20132):257\u2013261","journal-title":"Brain Res"},{"issue":"4","key":"9469_CR22","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.neures.2006.05.003","volume":"55","author":"M Ganzella","year":"2006","unstructured":"Ganzella M, Jardim FM, Boeck CR, Vendite D (2006) Time course of oxidative events in the hippocampus following intracerebroventricular infusion of quinolinic acid in mice. Neurosci Res 55(4):397\u2013402","journal-title":"Neurosci Res"},{"issue":"1","key":"9469_CR23","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pnpbp.2011.08.010","volume":"36","author":"P Gasso","year":"2012","unstructured":"Gasso P, Mas S, Molina O, Bernardo M, Lafuente A, Parellada E (2012) Neurotoxic\/neuroprotective activity of haloperidol, risperidone and paliperidone in neuroblastoma cells. Prog Neuropsychopharmacol Biol Psychiatry 36(1):71\u201377","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"4","key":"9469_CR24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","volume":"15","author":"CR Gerfen","year":"1992","unstructured":"Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15(4):133\u2013139","journal-title":"Trends Neurosci"},{"issue":"2","key":"9469_CR25","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0021-9258(18)57021-6","volume":"177","author":"AG Gornall","year":"1949","unstructured":"Gornall AG, Bardawill CJ, David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177(2):751\u2013766","journal-title":"J Biol Chem"},{"issue":"1","key":"9469_CR26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite, and [15\u00a0N]nitrate in biological fluids. Anal Biochem 126(1):131\u2013138","journal-title":"Anal Biochem"},{"issue":"12","key":"9469_CR27","doi-asserted-by":"crossref","first-page":"3513","DOI":"10.1111\/j.1460-9568.2007.05625.x","volume":"25","author":"RA Henry","year":"2007","unstructured":"Henry RA, Hughes SM, Connor B (2007) AAV-mediated delivery of BDNF augments neurogenesis in the normal and quinolinic acid-lesioned adult rat brain. Eur J Neurosci 25(12):3513\u20133525","journal-title":"Eur J Neurosci"},{"issue":"3","key":"9469_CR28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1017\/S1355617707070671","volume":"13","author":"SC Hinton","year":"2007","unstructured":"Hinton SC, Paulsen JS, Hoffmann RG, Reynolds NC, Zimbelman JL, Rao SM (2007) Motor timing variability increases in preclinical Huntington\u2019s disease patients as estimated onset of motor symptoms approaches. J Int Neuropsychol Soc 13(3):539\u2013543","journal-title":"J Int Neuropsychol Soc"},{"issue":"5","key":"9469_CR29","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/j.1471-4159.2006.04327.x","volume":"100","author":"RL Hunter","year":"2007","unstructured":"Hunter RL, Dragicevic N, Seifert K, Choi DY, Liu M, Kim HC, Cass WA, Sullivan PG, Bing G (2007) Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system. J Neurochem 100(5):1375\u20131386","journal-title":"J Neurochem"},{"issue":"3","key":"9469_CR30","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1212\/01.wnl.0000198586.85250.13","volume":"66","author":"Huntington Study Group","year":"2006","unstructured":"Huntington Study Group (2006) Tetrabenazine as antichorea therapy in Huntington disease: a randomized controlled trial. Neurology 66(3):366\u2013372","journal-title":"Neurology"},{"issue":"6","key":"9469_CR31","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0166-2236(00)01568-X","volume":"23","author":"RJ Jakel","year":"2000","unstructured":"Jakel RJ, Maragos WF (2000) Neuronal cell death in Huntington\u2019s disease: a potential role for dopamine. Trends Neurosci 23(6):239\u2013245","journal-title":"Trends Neurosci"},{"issue":"4","key":"9469_CR32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s12640-012-9315-x","volume":"22","author":"H Kalonia","year":"2012","unstructured":"Kalonia H, Mishra J, Kumar A (2012) Targeting neuro-inflammatory cytokines and oxidative stress by minocycline attenuates quinolinic acid induced Huntington\u2019s disease-like symptoms in rats. Neurotox Res 22(4):310\u2013320","journal-title":"Neurotox Res"},{"key":"9469_CR33","doi-asserted-by":"crossref","unstructured":"King TE (1967) Preparation of succinate dehydrogenase and reconstitution of succinate oxidase. In: Estabrook RD, Pullman ME (eds) Methods enzymol, vol 10. Academic Press, New York, pp 322\u2013331","DOI":"10.1016\/0076-6879(67)10061-X"},{"key":"9469_CR34","unstructured":"King TE, Howard RL (1967) Preparations and properties of soluble NADH dehydrogenases from cardiac muscle. In: Estabrook RD, Pullman ME (eds) Methods Enzymol, vol 10. Academic Press, New York, pp 275\u2013294"},{"issue":"1","key":"9469_CR35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0165-0270(97)00042-3","volume":"75","author":"K Klapdor","year":"1997","unstructured":"Klapdor K, Dulfer BG, Hammann A, Van der Staay FJ (1997) A low-cost method to analyse footprint patterns. J Neurosci Methods 75(1):49\u201354","journal-title":"J Neurosci Methods"},{"issue":"7684","key":"9469_CR36","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0140-6736(70)90367-3","volume":"2","author":"HC Klawans","year":"1970","unstructured":"Klawans HC, Paulson GW, Barbeau A (1970) Predictive test for Huntington\u2019s chorea. Lancet 2(7684):1185\u20131186","journal-title":"Lancet"},{"issue":"1","key":"9469_CR37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0003-9861(78)90479-4","volume":"186","author":"Y Kono","year":"1978","unstructured":"Kono Y (1978) Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archiv Biochem Biophys 186(1):189\u2013195","journal-title":"Archiv Biochem Biophys"},{"issue":"1\u20133","key":"9469_CR38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejphar.2013.10.057","volume":"720","author":"A Kumar","year":"2013","unstructured":"Kumar A, Chaudhary T, Mishra J (2013a) Minocycline modulates neuroprotective effect of hesperidin against quinolinic acid induced Huntington\u2019s disease like symptoms in rats: behavioral, biochemical, cellular and histological evidences. Eur J Pharmacol 720(1\u20133):16\u201328","journal-title":"Eur J Pharmacol"},{"issue":"1\u20133","key":"9469_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2013.03.042","volume":"709","author":"A Kumar","year":"2013","unstructured":"Kumar A, Sharma N, Mishra J, Kalonia H (2013b) Synergistical neuroprotection of rofecoxib and statins against malonic acid induced Huntington\u2019s disease like symptoms and related cognitive dysfunction in rats. Eur J Pharmacol 709(1\u20133):1\u201312","journal-title":"Eur J Pharmacol"},{"issue":"5","key":"9469_CR40","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.1471-4159.2003.01595.x","volume":"84","author":"I Lastres-Becker","year":"2003","unstructured":"Lastres-Becker I, de Miguel R, De Petrocellis L, Makriyannis A, Di Marzo V, Fernandez-Ruiz J (2003) Compounds acting at the endocannabinoid and\/or endovanilloid systems reduce hyperkinesia in a rat model of Huntington\u2019s disease. J Neurochem 84(5):1097\u20131109","journal-title":"J Neurochem"},{"issue":"2","key":"9469_CR41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.pnpbp.2012.03.011","volume":"38","author":"EC Lauterbach","year":"2012","unstructured":"Lauterbach EC (2012) Psychotropic drug effects on gene transcriptomics relevant to Parkinson\u2019s disease. Prog Neuropsychopharmacol Biol Psychiatry 38(2):107\u2013115","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"11","key":"9469_CR42","doi-asserted-by":"crossref","first-page":"22558","DOI":"10.3390\/ijms141122558","volume":"14","author":"E Lauterbach","year":"2013","unstructured":"Lauterbach E (2013) Neuroprotective effects of psychotropic drugs in Huntington\u2019s disease. Int J Mol Sci 14(11):22558\u201322603","journal-title":"Int J Mol Sci"},{"key":"9469_CR43","unstructured":"Lillie RD (1965) Histopathologic technic and practical histochemistry, 3rd edn. McGraw-Hill Book Co., New York"},{"issue":"2","key":"9469_CR44","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1046\/j.1471-4159.1997.69020581.x","volume":"69","author":"Y Liu","year":"1997","unstructured":"Liu Y, Peterson DA, Kimura H, Schubert D (1997) Mechanism of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. J Neurochem 69(2):581\u2013593","journal-title":"J Neurochem"},{"key":"9469_CR45","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/B978-0-12-395630-9.50158-4","volume-title":"Methods of enzymatic analysis","author":"H Luck","year":"1965","unstructured":"Luck H (1965) Catalase. In: Hans UB (ed) Methods of enzymatic analysis, 2nd edn. Academic Press, New York, pp 885\u2013894","edition":"2"},{"issue":"5\u20136","key":"9469_CR46","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1159\/000111684","volume":"14","author":"A Macaya","year":"1992","unstructured":"Macaya A, Burke RE (1992) Effect of striatal lesion with quinolinate on the development of substantia nigra dopaminergic neurons: a quantitative morphological analysis. Dev Neurosci 14(5\u20136):362\u2013368","journal-title":"Dev Neurosci"},{"issue":"4","key":"9469_CR47","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0306-4522(96)00655-0","volume":"78","author":"AF Miranda","year":"1997","unstructured":"Miranda AF, Boegman RJ, Beninger RJ, Jhamandas K (1997) Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid. Neuroscience 78(4):967\u2013975","journal-title":"Neuroscience"},{"key":"9469_CR48","author":"J Mishra","year":"2014","unstructured":"Mishra J, Chaudhary T, Kumar A (2014) Rosiglitazone synergizes the neuroprotective effects of valproic acid against quinolinic acid-induced neurotoxicity in rats: targeting PPARgamma and HDAC pathways. Neurotox Res. doi: 10.1007\/s12640-014-9458-z","journal-title":"Neurotox Res"},{"issue":"2","key":"9469_CR49","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jchromb.2005.01.008","volume":"818","author":"BA Patel","year":"2005","unstructured":"Patel BA, Arundell M, Parker KH, Yeoman MS, O\u2019Hare D (2005) Simple and rapid determination of serotonin and catecholamines in biological tissue using high-performance liquid chromatography with electrochemical detection. J Chromatogr B 818(2):269\u2013276","journal-title":"J Chromatogr B"},{"key":"9469_CR50","volume-title":"The rat brain in stereotaxic coordinates","author":"G Paxinos","year":"2007","unstructured":"Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates, 6th edn. Academic Press, San Diego","edition":"6"},{"issue":"1","key":"9469_CR51","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.schres.2013.03.006","volume":"147","author":"L Peng","year":"2013","unstructured":"Peng L, Zhu D, Feng X, Dong H, Yue Q, Zhang J, Gao Q, Hao J, Zhang X, Liu Z, Sun J (2013) Paliperidone protects prefrontal cortical neurons from damages caused by MK-801 via Akt1\/GSK3\u03b2 signaling pathway. Schizophr Res 147(1):14\u201323","journal-title":"Schizophr Res"},{"issue":"4","key":"9469_CR52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1093\/ilar.48.4.356","volume":"48","author":"S Ramaswamy","year":"2007","unstructured":"Ramaswamy S, McBride JL, Kordower JH (2007) Animal models of Huntington\u2019s disease. ILAR J 48(4):356\u2013373","journal-title":"ILAR J"},{"issue":"1","key":"9469_CR53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","volume":"68","author":"E Richelson","year":"2000","unstructured":"Richelson E, Souder T (2000) Binding of antipsychotic drugs to human brain receptors: focus on newer generation compounds. Life Sci 68(1):29\u201339","journal-title":"Life Sci"},{"issue":"9","key":"9469_CR54","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jpsychires.2011.02.007","volume":"45","author":"NM Richtand","year":"2011","unstructured":"Richtand NM, Ahlbrand R, Horn P, Stanford K, Bronson SL, McNamara RK (2011) Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. J Psychiatr Res 45(9):1194\u20131201","journal-title":"J Psychiatr Res"},{"issue":"3","key":"9469_CR55","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.neulet.2011.06.011","volume":"500","author":"NL Roenker","year":"2011","unstructured":"Roenker NL, Gudelsky G, Ahlbrand R, Bronson SL, Kern JR, Waterman H, Richtand NM (2011) Effect of paliperidone and risperidone on extracellular glutamate in the prefrontal cortex of rats exposed to prenatal immune activation or MK-801. Neurosci Lett 500(3):167\u2013171","journal-title":"Neurosci Lett"},{"key":"9469_CR56","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(01)02504-6","volume":"318","author":"JI Rossato","year":"2002","unstructured":"Rossato JI, Zeni G, Mello CF, Rubin MA, Rocha JB (2002) Ebselen blocks the quinolinic acid-induced production of thiobarbituric acid reactive species but does not prevent the behavioral alterations produced by intra-striatal quinolinic acid administration in the rat. Neurosci Lett 318:137\u2013140","journal-title":"Neurosci Lett"},{"key":"9469_CR57","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1038\/cddis.2010.31","volume":"1","author":"A Ruiz","year":"2010","unstructured":"Ruiz A, Matute C, Alberdi E (2010) Intracellular Ca2+ release through ryanodine receptors contributes to AMPA receptor-mediated mitochondrial dysfunction and ER stress in oligodendrocytes. Cell Death Dis 1:e54","journal-title":"Cell Death Dis"},{"issue":"1\u20132","key":"9469_CR58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0304-3940(93)90796-N","volume":"159","author":"A Santamaria","year":"1993","unstructured":"Santamaria A, Rios C (1993) MK-801, an N-methyl-d-aspartate receptor antagonist, blocks quinolinic acid-induced lipid peroxidation in rat corpus striatum. Neurosci Lett 159(1\u20132):51\u201354","journal-title":"Neurosci Lett"},{"key":"9469_CR59","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.bbr.2006.10.004","volume":"176","author":"ML Scattoni","year":"2007","unstructured":"Scattoni ML, Valanzano A, Pezzola A, March ZD, Fusco FR, Popoli P, Calamandrei G (2007) Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington\u2019s disease. Behav Brain Res 176:216\u2013221","journal-title":"Behav Brain Res"},{"issue":"7","key":"9469_CR60","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/S0278-5846(98)00070-0","volume":"22","author":"DA Shear","year":"1998","unstructured":"Shear DA, Dong J, Gundy CD, Haik-Creguer KL, Dunbar GL (1998) Comparison of intrastriatal injections of quinolinic acid and 3-nitropropionic acid for use in animal models of Huntington\u2019s disease. Prog Neuro Psychopharmacol Biol Psychiatry 22(7):1217\u20131240","journal-title":"Prog Neuro Psychopharmacol Biol Psychiatry"},{"key":"9469_CR61","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1083\/jcb.32.2.415","volume":"32","author":"GL Sottocasa","year":"1967","unstructured":"Sottocasa GL, Kuylenstierna B, Ernster L, Bergstrand A (1967) An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study. J Cell Biol 32:415\u2013438","journal-title":"J Cell Biol"},{"key":"9469_CR62","first-page":"13","volume":"13","author":"H Suzuki","year":"2013","unstructured":"Suzuki H, Gen K, Inoue Y, Hibino H, Mikami A, Matsumoto H, Mikami K (2013) The influence of switching from risperidone to paliperidone on the extrapyramidal symptoms and cognitive function in elderly patients with schizophrenia: a preliminary open-label trial. Int J Psychiatry Clin Pract 13:13","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"7","key":"9469_CR63","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1073\/pnas.0409402102","volume":"102","author":"TS Tang","year":"2005","unstructured":"Tang TS, Slow E, Lupu V, Stavrovskaya IG, Sugimori M, Llinas R, Kristal BS, Hayden MR, Bezprozvanny I (2005) Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington\u2019s disease. Proc Natl Acad Sci USA 102(7):2602\u20132607","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"9469_CR64","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1124\/dmd.107.018275","volume":"36","author":"M Vermeir","year":"2008","unstructured":"Vermeir M, Naessens I, Remmerie B, Mannens G, Hendrickx J, Sterkens P, Talluri K, Boom S, Eerdekens M, van Osselaer N, Cleton A (2008) Absorption, metabolism, and excretion of paliperidone, a new monoaminergic antagonist, in humans. Drug Metab Dispos 36(4):769\u2013779","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"9469_CR65","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","volume":"57","author":"JP Vonsattel","year":"1998","unstructured":"Vonsattel JP, DiFiglia M (1998) Huntington disease. J Neuropathol Exp Neurol 57(5):369\u2013384","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"9469_CR66","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1042\/bj0990667","volume":"99","author":"ED Wills","year":"1966","unstructured":"Wills ED (1966) Mechanisms of lipid peroxide formation in animal tissues. Biochem J 99(3):667\u2013676","journal-title":"Biochem J"},{"issue":"3","key":"9469_CR67","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s00213-011-2291-7","volume":"217","author":"MC Yang","year":"2011","unstructured":"Yang MC, Lung FW (2011) Neuroprotection of paliperidone on SH-SY5Y cells against beta-amyloid peptide (25-35), N-methyl-4-phenylpyridinium ion, and hydrogen peroxide-induced cell death. Psychopharmacology 217(3):397\u2013410","journal-title":"Psychopharmacology"},{"issue":"4","key":"9469_CR68","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0021-9258(19)81724-6","volume":"243","author":"WL Zahler","year":"1968","unstructured":"Zahler WL, Cleland WW (1968) A specific and sensitive assay for disulfides. J Biol Chem 243(4):716\u2013719","journal-title":"J Biol Chem"},{"issue":"5\u20136","key":"9469_CR69","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.pneurobio.2007.01.003","volume":"81","author":"C Zuccato","year":"2007","unstructured":"Zuccato C, Cattaneo E (2007) Role of brain-derived neurotrophic factor in Huntington\u2019s disease. Prog Neurobiol 81(5\u20136):294\u2013330","journal-title":"Prog Neurobiol"}],"container-title":["Neurotoxicity Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9469-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12640-014-9469-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12640-014-9469-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T13:50:25Z","timestamp":1746193825000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12640-014-9469-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,22]]},"references-count":69,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["9469"],"URL":"https:\/\/doi.org\/10.1007\/s12640-014-9469-9","relation":{},"ISSN":["1029-8428","1476-3524"],"issn-type":[{"type":"print","value":"1029-8428"},{"type":"electronic","value":"1476-3524"}],"subject":[],"published":{"date-parts":[[2014,4,22]]}}}